Who invested in GenomePrecision?
GenomePrecision's investors include Oriental Fortune Capital and China Growth Capital.
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$31Mraised across 1 round since 2021, from 1 source
GenomePrecision's investors include Oriental Fortune Capital and China Growth Capital.
GenomePrecision has raised $31M across 1 round since 2021.
GenomePrecision's most recent round was a Series C of $31M in Apr 2021.
Its most recent round, $31M in Apr 2021, is also its largest on record.
GenomePrecision's first round on record, in Apr 2021, was backed by Oriental Fortune Capital and China Growth Capital.
GenomePrecision's latest named round is a Series C, in Apr 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.